Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

December 2001

Volume 953b DRUG-RESISTANT TUBERCULOSIS: FROM MOLECULES TO MACRO-ECONOMICS

Pages 87–246

  1. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Introduction

    1. Top of page
    2. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Introduction
    3. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part I. The Scale of the Problem
    4. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part II. Scientific Basis of Drug-Resistant Tuberculosis
    5. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part III. Clinical Aspects of Drug Resistance
    6. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part IV. Practicalities of Prevention
    7. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part V. Coercion or Commitment: Policies of Prevention
    8. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part VI. The Future
    1. Introduction (page 87)

      Peter Davies

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11363.x

  2. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part I. The Scale of the Problem

    1. Top of page
    2. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Introduction
    3. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part I. The Scale of the Problem
    4. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part II. Scientific Basis of Drug-Resistant Tuberculosis
    5. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part III. Clinical Aspects of Drug Resistance
    6. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part IV. Practicalities of Prevention
    7. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part V. Coercion or Commitment: Policies of Prevention
    8. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part VI. The Future
    1. The Burden of Drug-Resistant Tuberculosis and Mechanisms for Its Control (pages 88–97)

      MARIO C. RAVIGLIONE, RAJESH GUPTA, CHRISTOPHER M. DYE and MARCOS A. ESPINAL

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11364.x

    2. India's Multidrug-Resistant Tuberculosis Crisis (pages 98–105)

      ZARIR F. UDWADIA

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11365.x

    3. Drug-Resistant Tuberculosis in Africa (pages 106–112)

      A. MWINGA

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11366.x

    4. Tuberculosis in Russia and the Problem of Multiple Drug Resistance (pages 133–137)

      V. V. YEROKHIN, V. V. PUNGA and L. N. RYBKA

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11370.x

  3. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part II. Scientific Basis of Drug-Resistant Tuberculosis

    1. Top of page
    2. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Introduction
    3. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part I. The Scale of the Problem
    4. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part II. Scientific Basis of Drug-Resistant Tuberculosis
    5. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part III. Clinical Aspects of Drug Resistance
    6. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part IV. Practicalities of Prevention
    7. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part V. Coercion or Commitment: Policies of Prevention
    8. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part VI. The Future
    1. The Genetics of Host Resistance and Susceptibility to Tuberculosis (pages 151–156)

      PETER DAVIES and JOHN GRANGE

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11373.x

    2. Pharmacological Issues in the Treatment of Tuberculosis (pages 157–164)

      CHARLES A. PELOQUIN

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11374.x

  4. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part III. Clinical Aspects of Drug Resistance

    1. Top of page
    2. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Introduction
    3. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part I. The Scale of the Problem
    4. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part II. Scientific Basis of Drug-Resistant Tuberculosis
    5. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part III. Clinical Aspects of Drug Resistance
    6. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part IV. Practicalities of Prevention
    7. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part V. Coercion or Commitment: Policies of Prevention
    8. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part VI. The Future
    1. DOTS and DOTS-Plus : Not the Only Answer (pages 165–184)

      PAUL FARMER

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11375.x

  5. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part IV. Practicalities of Prevention

    1. Top of page
    2. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Introduction
    3. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part I. The Scale of the Problem
    4. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part II. Scientific Basis of Drug-Resistant Tuberculosis
    5. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part III. Clinical Aspects of Drug Resistance
    6. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part IV. Practicalities of Prevention
    7. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part V. Coercion or Commitment: Policies of Prevention
    8. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part VI. The Future
    1. The Clinical Management of the Drug-Resistant Patient (pages 185–191)

      PETER ORMEROD

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11376.x

    2. Multidrug-Resistant Tuberculosis and HIV Infection (pages 192–198)

      ANTON POZNIAK

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11377.x

    3. Holding the Patient (pages 199–207)

      GINI WILLIAMS

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11378.x

  6. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part V. Coercion or Commitment: Policies of Prevention

    1. Top of page
    2. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Introduction
    3. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part I. The Scale of the Problem
    4. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part II. Scientific Basis of Drug-Resistant Tuberculosis
    5. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part III. Clinical Aspects of Drug Resistance
    6. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part IV. Practicalities of Prevention
    7. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part V. Coercion or Commitment: Policies of Prevention
    8. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part VI. The Future
    1. Missed Opportunities? : Coercion or Commitment: Policies of Prevention (pages 224–232)

      JOHN D.H. PORTER and JESSICA A. OGDEN

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11381.x

  7. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part VI. The Future

    1. Top of page
    2. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Introduction
    3. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part I. The Scale of the Problem
    4. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part II. Scientific Basis of Drug-Resistant Tuberculosis
    5. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part III. Clinical Aspects of Drug Resistance
    6. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part IV. Practicalities of Prevention
    7. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part V. Coercion or Commitment: Policies of Prevention
    8. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics: Part VI. The Future
    1. Multidrug-Resistant Tuberculosis : This Is the Cost (pages 233–240)

      John Moore-Gillon

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11382.x

    2. Drug-Resistant Tuberculosis : Concluding Remarks (pages 241–246)

      PETER D.O. DAVIES

      Version of Record online: 10 FEB 2006 | DOI: 10.1111/j.1749-6632.2001.tb11383.x

SEARCH

SEARCH BY CITATION